We have previously shown that the heterozygous p.I171V mutation of the NBN gene may contribute to laryngeal cancer (OR=11.7, 95% CI 1.3–105.2) and multiple primary tumors (OR=28.35, 95% CI 3.27–245.7) [9]. Here, NBN is linked to laryngeal carcinoma.